Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pfizer
Biotech
Pfizer signs $1.9B pact for Fosun unit's GLP-1 drug
Pfizer’s bidding war for Metsera hasn’t satiated the pharma’s appetite for GLP-1 therapies—at least going by this morning’s $1.9 billion biobucks deal.
James Waldron
Dec 9, 2025 8:00am
Pfizer Ventures gets behind Chinese biotech's $100M series A
Dec 5, 2025 4:20am
Pfizer details phase 3 data for mRNA flu vaccine
Nov 20, 2025 11:25am
Pfizer finalizes Metsera buy after contentious Novo bidding war
Nov 13, 2025 12:43pm
Pfizer lays out its PD-1xVEGF bispecific research strategy
Nov 11, 2025 11:43am
Pfizer beats out Novo with $10B agreement to buy Metsera
Nov 8, 2025 8:11am